Associate Professor Ricky Johnstone
Assistant Director of Research Peter MacCallum Cancer Centre

Associate Professor Johnstone is a Assistant Director of Research, Peter MacCallum Cancer Centre.
Program Co-Head, Cancer Therapeutics Program, Peter MacCallum Cancer Centre and Group Leader, Gene Regulation Laboratory, Peter MacCallum Cancer Centre.
Ricky is also a past Pfizer Fellowship winner. Ricky has worked at the Harvard Medical School and has been the recipient of a Wellcome Trust Fellowship. Ricky’s research is concerned with understanding the molecular events underpinning cancer cell death by chemotherapeutic-drugs, determining how tumours become multidrug resistant (MDR), and identifying and characterising new drugs designed to circumvent cancer cell MDR.

Professor Mark Smyth
Senior Research Fellow Peter MacCallum Cancer Centre

Professor Mark Smyth has been Head of the Cancer Immunology Program at the Peter MacCallum Cancer Center in Melbourne since 2000. Professor Mark Smyth is a leader in immunity and its relevance to new cancer therapies. His research has recently identified the pivotal role played by cytotoxic lymphocytes in identifying and destroying cancer cells before they can have a clinical impact. Involvement of the immune system in cancer “surveillance” is an important aspect to new cancer therapies.

Professor Dale Godfrey
Research Group Leader, Department of Microbiology and Immunology University of Melbourne

Professor Dale Godfrey is a Laboratory Group Leader at the Department of Microbiology and Immunology and the University of Melbourne. www.microbiol.unimelb.edu.au/research/groups/godfrey Dale is a member of the Immune Regulation, Effector Function and Human Therapy Research program in conjunction with Peter MacCallum’s Joe Trapani, Mark Smyth and Ricky Johnstone’s labs. His research has been directed at the role of NKT cells in immune response and the central role that NKT cells play in host response against tumours. Dale has a strong record of publications in leading journals and his work is directed at new cancer immunotherapies.

Dr Erika Cretney
Researcher

Dr Erika Cretney is engaged by Genscreen on a part-time basis to assist in project investigation and technology assessment. Erika has conducted leading research into the molecule TRAIL and its involvement in cancer. Erika has been the winner of the 2005 Victoria Fellows award and won the Premier’s Award for Medical Research in 2004. Erika obtained a Cancer Council Victoria Fellowship and won the 2004 Peter Mac Postgraduate Research Medal.